These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34155298)

  • 1. Plasma lipidomic analysis shows a disease progression signature in mdx mice.
    Tsonaka R; Seyer A; Aartsma-Rus A; Spitali P
    Sci Rep; 2021 Jun; 11(1):12993. PubMed ID: 34155298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
    Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
    Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal metabolomic analysis of plasma enables modeling disease progression in Duchenne muscular dystrophy mouse models.
    Tsonaka R; Signorelli M; Sabir E; Seyer A; Hettne K; Aartsma-Rus A; Spitali P
    Hum Mol Genet; 2020 Mar; 29(5):745-755. PubMed ID: 32025735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent changes in metabolite profile and lipid saturation in dystrophic mice.
    Lee-McMullen B; Chrzanowski SM; Vohra R; Forbes SC; Vandenborne K; Edison AS; Walter GA
    NMR Biomed; 2019 May; 32(5):e4075. PubMed ID: 30848538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of imaging biomarkers to assess perfusion and glucose metabolism in the skeletal muscle of dystrophic mice.
    Ahmad N; Welch I; Grange R; Hadway J; Dhanvantari S; Hill D; Lee TY; Hoffman LM
    BMC Musculoskelet Disord; 2011 Jun; 12():127. PubMed ID: 21639930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models.
    Mázala DA; Pratt SJP; Chen D; Molkentin JD; Lovering RM; Chin ER
    Am J Physiol Cell Physiol; 2015 May; 308(9):C699-709. PubMed ID: 25652448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of a model of Duchenne muscular dystrophy in blood serum of mdx mice using Raman hyperspectroscopy.
    Ralbovsky NM; Dey P; Galfano A; Dey BK; Lednev IK
    Sci Rep; 2020 Jul; 10(1):11734. PubMed ID: 32678134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
    Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
    Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
    Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
    J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients.
    Hathout Y; Marathi RL; Rayavarapu S; Zhang A; Brown KJ; Seol H; Gordish-Dressman H; Cirak S; Bello L; Nagaraju K; Partridge T; Hoffman EP; Takeda S; Mah JK; Henricson E; McDonald C
    Hum Mol Genet; 2014 Dec; 23(24):6458-69. PubMed ID: 25027324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic-metabolic reprogramming.
    Quattrocelli M; Zelikovich AS; Jiang Z; Peek CB; Demonbreun AR; Kuntz NL; Barish GD; Haldar SM; Bass J; McNally EM
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31852847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of myofiber branching via muscle-specific expression of the olfactory receptor mOR23 in dystrophic muscle leads to protection against mechanical stress.
    Pichavant C; Burkholder TJ; Pavlath GK
    Skelet Muscle; 2016; 6():2. PubMed ID: 26798450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin improves muscle function of the dystrophic mdx5Cv mouse, a model for Duchenne muscular dystrophy.
    Hibaoui Y; Reutenauer-Patte J; Patthey-Vuadens O; Ruegg UT; Dorchies OM
    J Pineal Res; 2011 Sep; 51(2):163-71. PubMed ID: 21486366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy.
    Fontelonga TM; Jordan B; Nunes AM; Barraza-Flores P; Bolden N; Wuebbles RD; Griner LM; Hu X; Ferrer M; Marugan J; Southall N; Burkin DJ
    Hum Mol Genet; 2019 Jul; 28(13):2120-2132. PubMed ID: 30806670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurine deficiency, synthesis and transport in the mdx mouse model for Duchenne Muscular Dystrophy.
    Terrill JR; Grounds MD; Arthur PG
    Int J Biochem Cell Biol; 2015 Sep; 66():141-8. PubMed ID: 26239309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment.
    González-Sánchez J; Sánchez-Temprano A; Cid-Díaz T; Pabst-Fernández R; Mosteiro CS; Gallego R; Nogueiras R; Casabiell X; Butler-Browne GS; Mouly V; Relova JL; Pazos Y; Camiña JP
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1063-1078. PubMed ID: 30216693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of qPCR Reference Genes Suitable for Normalizing Gene Expression in a Canine Model of Duchenne Muscular Dystrophy.
    Hildyard JCW; Taylor-Brown F; Massey C; Wells DJ; Piercy RJ
    J Neuromuscul Dis; 2018; 5(2):177-191. PubMed ID: 29614692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
    Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
    Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.